Serum levels of soluble programmed death-ligand 1 (sPD-L1) in patients with primary central nervous system diffuse large B-cell lymphoma

BACKGROUND: The interaction of programmed death-1 protein (PD-1) and programmed death-1 ligand (PD-L1) produces immunosuppressive activity, protecting tumor cells from anti-tumor immunity and possibly releasing soluble PD-L1 (sPD-L1) from PD-L1 expressing tumor cells. Therefore, we measured serum le...

Descripción completa

Detalles Bibliográficos
Autores principales: Cho, Inju, Lee, Hansang, Yoon, Sang Eun, Ryu, Kyung Ju, Ko, Young Hyeh, Kim, Won Seog, Kim, Seok Jin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7020571/
https://www.ncbi.nlm.nih.gov/pubmed/32054467
http://dx.doi.org/10.1186/s12885-020-6612-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7020571/
https://www.ncbi.nlm.nih.gov/pubmed/32054467
http://dx.doi.org/10.1186/s12885-020-6612-2

Ejemplares similares